Malignant melanomas are typically hard to treat as they are resistant to apoptosis induced by chemotherapy drugs, despite the presence of a functional p53 gene. Recent studies have shed light on the mysteries of malignant melanomas and identified key molecules that may serve as future drug targets to treat skin cancer.
Go to Previous Page
Go to Next Page